Table 1 Clinical data and laboratory parameters of the study subjects
Group | AIA (\(n=23\)) | ATA (\(n=17\)) | NPwA (\(n=15\)) |
|---|---|---|---|
Male/female (n) | 11/12 | 12/4 | 11/4 |
Age in years, mean (range) | 48.7 (18–70) | 51.2 (40–67) | 43.2 (19–68) |
Asthmatic patients, n | 23 | 17 | 0 |
Atopic patients, n (%) | 8 (34%) | 8 (47%) | 0 |
Number of previous FESS operations; mean (range) | 2 (1–8) | 1.4 (1–6) | 1.38 (1–2) |
Absolute eosinophilic blood counts (Gpt/l); mean (range) | 0.486 (0.134–0.872) | 0.263 (0.079–0.458) | 0.116 (0.1–0.15) |
Eosinophilic infiltrations in nasal polyps, n (%) | 18 (78.3%) | 14 (82.3%) | 11 (73.3%) |
Eosinophilic infiltrations in bronchial mucosa, n (%) | 5 (21.7%) | 3 (17.6%) | 1 (6.6%) |